Evidence map›Paper›PMID 34493903›Full record

ArticleSensors and actuators. B, Chemical2021

SERS-based lateral flow immunoassay for sensitive and simultaneous detection of anti-SARS-CoV-2 IgM and IgG antibodies by using gap-enhanced Raman nanotags.

Shiliang Chen, Liuwei Meng, Litong Wang, Xixi Huang, Shujat Ali, Xiaojing Chen, Mingen Yu, Ming Yi, Limin Li, Xi Chen and 3 more

Open access · greenAbstract read
In one paragraph

Article in Sensors and actuators. B, Chemical, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 87 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Shiliang ChenCollege of Electrical and Electronic Engineering, Wenzhou University, Wenzhou 325035, PR China.
Liuwei MengCollege of Electrical and Electronic Engineering, Wenzhou University, Wenzhou 325035, PR China.
Litong WangResearch and Development Department, Hangzhou Goodhere Biotechnology Co.,Ltd., Hangzhou 311100, PR China.
Xixi HuangCollege of Electrical and Electronic Engineering, Wenzhou University, Wenzhou 325035, PR China.
Shujat AliCollege of Electrical and Electronic Engineering, Wenzhou University, Wenzhou 325035, PR China.
Xiaojing ChenCollege of Electrical and Electronic Engineering, Wenzhou University, Wenzhou 325035, PR China.
Mingen YuResearch and Development Department, Hangzhou Goodhere Biotechnology Co.,Ltd., Hangzhou 311100, PR China.
Ming YiResearch and Development Department, Hangzhou Goodhere Biotechnology Co.,Ltd., Hangzhou 311100, PR China.
Limin LiCollege of Electrical and Electronic Engineering, Wenzhou University, Wenzhou 325035, PR China.
Xi ChenCollege of Electrical and Electronic Engineering, Wenzhou University, Wenzhou 325035, PR China.
Leiming YuanCollege of Electrical and Electronic Engineering, Wenzhou University, Wenzhou 325035, PR China.
Wen ShiCollege of Electrical and Electronic Engineering, Wenzhou University, Wenzhou 325035, PR China.
Guangzao HuangCollege of Electrical and Electronic Engineering, Wenzhou University, Wenzhou 325035, PR China.
Wenzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The lateral flow immunoassay (LFIA) has played a crucial role in early diagnosis during the current COVID-19 pandemic owing to its simplicity, speed and affordability for coronavirus antibody detection. However, the sensitivity of the commercially available LFIAs needs to be improved to better prevent the spread of the infection. Here, we developed an ultra-sensitive surface-enhanced Raman scattering-based lateral flow immunoassay (SERS-based LFIA) strip for simultaneous detection of anti-SARS-CoV-2 IgM and IgG by using gap-enhanced Raman nanotags (GERTs). The GERTs with a 1 nm gap between the core and shell were used to produce the "hot spots", which provided about 30-fold enhancement as compared to conventional nanotags. The COVID-19 recombinant antigens were conjugated on GERTs surfaces and replaced the traditional colloidal gold for the Raman sensitive detection of human IgM and IgG. The LODs of IgM and IgG were found to be 1 ng/mL and 0.1 ng/mL (about 100 times decrease was observed as compared to commercially available LFIA strips), respectively. Moreover, under the condition of common nano-surface antigen, precise SERS signals proved the unreliability of quantitation because of the interference effect of IgM on IgG.

Indexed as

COVID-19Gap-enhanced Raman nanotags (GERTs)IgM/IgGLateral flow immunoassaySARS-CoV-2Surface-enhanced Raman scattering (SERS)

Identifiers

PMID34493903
PMCPMC8413105
OpenAlexW3197086477

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.